Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Enamel Matrix Derivative (Emdogain®) on Soft Tissue Wound Healing Following Surgical Crown Lengthening Procedures

NCT06179277 is registered in ClinicalTrials.gov with Amir Azarpazhooh as lead sponsor.

NCT NCT06179277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06179277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Enamel Matrix Derivative (Emdogain®) on Soft Tissue Wound Healing Following Surgical Crown Lengthening Procedures
Lead sponsor
Amir Azarpazhooh
Phase
Not applicable
Overall status
Completed
Start date
April 8, 2019
Completion date
October 11, 2021
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crown lengthening, periodontal inflammation